DCM
NDRM

DAFNA Capital Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

DAFNA Capital Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-37,938
Closed -$1.48M – 82
2017
Q3 		$1.48M Hold
37,938
– – 0.92% 36
2017
Q2 		$1.13M Buy
37,938
+500
+1% +$13K 0.81% 40
2017
Q1 		$994K Sell
37,438
-483
-1% -$12K 0.84% 34
2016
Q4 		$842K Buy
37,921
+23,500
+163% +$440K 0.74% 42
2016
Q3 		$267K Hold
14,421
– – 0.19% 64
2016
Q2 		$234K Buy
14,421
+13,219
+1,100% +$223K 0.19% 74
2016
Q1 		$17K Buy
+1,202
New +$16.2K 0.01% 93

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

DAFNA Capital Management's NDRM Position: Q4 2017 in Review

DAFNA Capital Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 37,938 shares — an estimated $1.48M sold.

DAFNA Capital Management first reported a position in NDRM in Q1 2016 and held it in 7 quarters. The position peaked at $1.48M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • DAFNA Capital Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • DAFNA Capital Management sold 37,938 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $1.48M.
  • DAFNA Capital Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q1 2016 and held it in 7 quarters.
  • DAFNA Capital Management's NeuroDerm Ltd. Ordinary Shares position peaked at $1.48M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on DAFNA Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.